This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Innospec (IOSP) Up 15% in 3 Months: What's Behind the Rally?
by Zacks Equity Research
Solid Q1 results and upbeat prospects have contributed to a rally in Innospec's (IOSP) shares.
Ashland (ASH) Shares Up 12% YTD: What's Driving the Stock?
by Anindya Barman
Forecast-topping Q2 earnings performance and upbeat outlook have contributed to the rally in Ashland's (ASH) shares.
PPG Industries to Open New Distribution Center in Texas
by Zacks Equity Research
PPG Industries (PPG) plans to open a new distribution center in Texas to strengthen its distribution model, which is expected to be completed in May 2019.
Univar (UNVR) Inks Distribution Deal With Colonial Chemical
by Zacks Equity Research
Univar's (UNVR) latest deal will expand its surfactant portfolio and address the growing demand for natural products in home care and personal care markets.
Air Products Enhances Asia Technology Center Capabilities
by Zacks Equity Research
Air Products (APD) upgrades Asia Technology Center in China that will support the fast-paced development of China and Asia markets through its advanced applications technologies.
Why Should You Add Versum Materials (VSM) to Your Portfolio?
by Zacks Equity Research
Healthy growth prospects and upbeat outlook make Versum Materials (VSM) an attractive investment option.
Eastman Chemical to Be Aided by Cost Actions, Acquisitions
by Zacks Equity Research
Strategic acquisitions and cost-cut actions by Eastman Chemical (EMN) are expected to drive growth, although raw material inflation prevail.
Here's Why You Should Add Hi-Crush (HCLP) to Your Portfolio
by Zacks Equity Research
Strong fundamentals and upbeat prospects make Hi-Crush (HCLP) an attractive investment choice.
U.S. Steel (X) to Reopen Second Blast Furnace in Illinois
by Zacks Equity Research
U.S. Steel's (X) move is expected to support the growing demand for steel made in the United States.
Eastman Chemical (EMN) to Increase Price of Plasticizers
by Zacks Equity Research
Eastman Chemical (EMN) is taking appropriate pricing actions in response to escalated operating costs including rising raw material and freight charges.
Chemours (CC) Raises Methylamines Prices in North America
by Zacks Equity Research
Chemours' (CC) latest move to increase Methylamines products prices is likely to provide margin benefits.
5 Reasons to Add Cleveland-Cliffs (CLF) to Your Portfolio Now
by Zacks Equity Research
Strong growth prospects and upbeat outlook make Cleveland-Cliffs (CLF) an attractive investment option.
DowDuPont's Unit to Invest Over $400M in Capacity Expansion
by Zacks Equity Research
DowDuPont's (DWDP) business unit intends to invest over $400 million in production expansion of Tyvek nonwoven materials at its Luxembourg facility that is expected to start in 2021.
Steel Dynamics (STLD) Stock Up 27% in 6 Months: Here's Why
by Zacks Equity Research
Forecast-topping earnings performance, upbeat guidance and the Trump administration's trade actions on steel imports have contributed to the rally in Steel Dynamics' (STLD) shares.
LyondellBasell (LYB) Gets a Nod for Share Repurchase Program
by Zacks Equity Research
LyondellBasell (LYB) receives a nod from its shareholders to repurchase up to 10% of its shares through open market or privately negotiated transactions.
Westlake Chemical Up 85% in a Year: What's Behind the Rally?
by Zacks Equity Research
Forecast-topping earnings performance and an upbeat outlook have contributed to a rally in Westlake Chemical's (WLK) shares.
Praxair (PX) Worth Buying on Solidifying Product Demand
by Zacks Equity Research
Strengthening end markets, growing U.S. and global economy, and increasing applications of industrial gases are likely to boost demand for Praxair's (PX) products in the quarters ahead.
AK Steel (AKS) Introduces Latest Product, TRAN-COR X
by Zacks Equity Research
AK Steel's (AKS) latest product TRAN-COR X provides higher levels of efficiency along with greenhouse gas emissions for use in high and ultra-high voltage power transformers.
Chemours Inks Deal to Facilitate Distribution of XP40 in EU
by Zacks Equity Research
Chemours (CC) inks a deal with Arkema to make XP40 more accessible to the customers in European Union.
Huntsman (HUN) Up 37% in a Year: What's Behind the Rally?
by Anindya Barman
Forecast-topping earnings performance, efforts to expand specialty businesses and focus on free cash flow generation have contributed to the rally in Huntsman's (HUN) shares.
Celanese (CE) Stock Up 31% in a Year: What's Driving It?
by Anindya Barman
Better-than-expected earnings performance, upbeat outlook for 2018 and compelling prospects have contributed to the rally in Celanese's (CE) shares.
DowDuPont's Unit to Sell Alginates Business to JRS Group
by Zacks Equity Research
DowDuPont's (DWDP) DuPont Nutrition & Health (N&H) unit receives a green signal from the EC to divest Alginates business to JRS Group in a deal that is expected to close in third-quarter 2018.
Methanex (MEOH) Up 62% in a Year: What's Behind the Rally?
by Zacks Equity Research
Methanex (MEOH) is riding high on healthy demand and pricing fundamentals for methanol.
Here's Why You Should Add Chemours (CC) to Your Portfolio
by Zacks Equity Research
Strong fundamentals and upbeat prospects make Chemours (CC) an attractive choice for investment.
Celanese Set to Raise Prices of Acetyl Intermediate Products
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment that are likely to lend support to margins.